title: Low incidence and severity of oral mucositis in allogeneic stem cell transplantation after conditioning with treosulfan and fludarabine.
authors: Uotinen
authors: U
authors: Heli
authors: Juvonen
authors: J
authors: Eeva
authors: Nihtinen
authors: N
authors: Anne
authors: Ruutu
authors: R
authors: Tapani
authors: Volin
authors: V
authors: Liisa
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage* / Q000009:adverse effects; D002066:Busulfan / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D019337:Hematologic Neoplasms / Q000473:pathology / Q000628:therapy; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D052016:Mucositis / Q000453:epidemiology* / Q000209:etiology / Q000473:pathology; D019653:Myeloablative Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D012720:Severity of Illness Index; D033581:Stem Cell Transplantation; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D014740:Vidarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D019653:Myeloablative Agonists; C018404:treosulfan; D014740:Vidarabine; D002066:Busulfan; C024352:fludarabine